REGISTERED
on 06 Aug 2024
Last Applicant/ Owned by
Ballindamm 39
HAMBURG
DE
20095
Serial Number
97627400 filed on 11th Oct 2022
Registration Number
7465095 registered on 06th Aug 2024
Correspondent Address
Mark F. Warzecha
Filing Basis
No Filing Basis
Disclaimer
NO DATA
GQ
Consulting services in the field of pharmaceutical research and development; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development in the field of genetics, gene therapy, cell therapy, vaccines, biotechnological production, non-viral and viral vector production; Pharmaceutical drug development services for prevention and trea Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Consulting services in the field of pharmaceutical research and development; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development in the field of genetics, gene therapy, cell therapy, vaccines, biotechnological production, non-viral and viral vector production; Pharmaceutical drug development services for prevention and treatment of musculoskeletal, genetic, ophthalmic, metabolic, endocrine, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Scientific research and development; Scientific research consulting in the field of genetics, gene therapy, cell therapy, vaccines, biotechnological production, and non-viral and viral vector production; Scientific research for medical purposes in the field of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Scientific research in the field of genetics and genetic engineering; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Vaccines; Analgesic preparations; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-inflammatory preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological skin tissues, liver tissues, and joint tissues, namely, bone, cartilage, synovium, and tendon tissues, all intended for subsequent implantation; Cells for medical or clinical use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical or veterinary purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Human vaccine preparations; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pain relief medication; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment and prevention of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Veterinary pharmaceutical preparations for the prevention of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, pulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Veterinary pharmaceutical preparations for the treatment of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, pulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Veterinary preparations, namely, pain relief medication; Veterinary vaccines; In vitro diagnostic preparations for medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Biomanufacturing for others, namely, manufacturing of biologics, vaccines, non-viral and viral vectors, and gene and cell therapy preparations, all using biological organisms in the manufacturing process; Custom manufacture of pharmaceuticals, biologics, vaccines, biotechnological products, non-viral and viral vectors, and gene and cell therapy preparations by pharmaceutical compounders; Custom manufacture of pharmaceuticals, biologics, vaccines, biotechnological medications, non-viral and viral vectors, and gene and cell therapy preparations; Manufacturing process consulting; Manufacturing services for others in the field of pharmaceuticals, biologics, vaccines, non-viral and viral vectors, and gene therapy and gene and cell therapy preparations; Technical support services, namely, providing technical advice related to the manufacture of biologics, gene therapy preparations, vaccines, non-viral and viral vectors
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97627400
Mark Type
No Service Mark
Attorney Docket Number
No 5091.00002
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Aug 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 20th Aug 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 20th Aug 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 20th Aug 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 20th Aug 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 20th Aug 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 06th Aug 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 06th Aug 2024 | REGISTERED-PRINCIPAL REGISTER |
| 21st May 2024 | PUBLISHED FOR OPPOSITION |
| 21st May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |